REN and hypertensive disorder: The profile of labetalol, an alpha/beta adrenergic antagonist use to treat essential hypertension, shows that its dose reduction is strongly and positively associated with prerenal renal failure and acute renal failure diagnostics as well as lab tests for renin activity and aldosterone (see Supplementary Fig. S2).